Analysis of Isocitrate Dehydrogenase -2 (IDH-2) Activity in Human Serum as a Biomarker in Chemotherapy Patients of Breast Carcinoma: A Case-Control Study
Introduction: Breast cancer represents a major public health problem in women worldwide. For many cancers, serum tumour markers play an important role in patient treatment and monitoring. Isocitrate dehydrogenase enzyme is also used as a biomarker for various types of cancer. Aim: The purpose o...
Main Authors: | Roshni Gavel, S.P. Mishra, Seema Khanna, Rahul Khanna, Agni Gautam Shah |
---|---|
Format: | Article |
Language: | English |
Published: |
JCDR Research and Publications Private Limited
2017-05-01
|
Series: | Journal of Clinical and Diagnostic Research |
Subjects: | |
Online Access: | https://jcdr.net/articles/PDF/9842/21886_CE(RA1)_F(T)_PF1(SwG_SS)_PFA(SwG_SS)_PF2(NE_AD_SS).pdf |
Similar Items
-
Identification of Isocitrate Dehydrogenase 2 (IDH2) Mutation in Carotid Body Paraganglioma
by: Fengchao Lang, et al.
Published: (2021-09-01) -
Molecular alterations of isocitrate dehydrogenase 1 and 2 (<it>IDH1 </it>and <it>IDH2</it>) metabolic genes and additional genetic mutations in newly diagnosed acute myeloid leukemia patients
by: Chotirat Sadudee, et al.
Published: (2012-03-01) -
Mutated Isocitrate Dehydrogenase (mIDH) as Target for PET Imaging in Gliomas
by: Felix Neumaier, et al.
Published: (2023-03-01) -
Metabolic characterization of isocitrate dehydrogenase (IDH) mutant and IDH wildtype gliomaspheres uncovers cell type-specific vulnerabilities
by: Matthew Garrett, et al.
Published: (2018-04-01) -
Isocitrate protects DJ-1 null dopaminergic cells from oxidative stress through NADP+-dependent isocitrate dehydrogenase (IDH).
by: Jinsung Yang, et al.
Published: (2017-08-01)